Karen Kaul to Pancreatic Neoplasms
This is a "connection" page, showing publications Karen Kaul has written about Pancreatic Neoplasms.
Connection Strength
0.458
-
Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. PLoS One. 2015; 10(10):e0139049.
Score: 0.090
-
Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2014 Dec; 156(6):1504-10; discussion 1510-1.
Score: 0.085
-
Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2013 Oct; 154(4):785-91; discussion 791-3.
Score: 0.078
-
Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers. PLoS One. 2011; 6(12):e29180.
Score: 0.069
-
Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer. 2010 Apr 01; 116(7):1674-80.
Score: 0.062
-
The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays. Mol Cell Proteomics. 2009 Jul; 8(7):1697-707.
Score: 0.058
-
Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases. Proteomics. 2011 Sep; 11(18):3665-74.
Score: 0.017